Ariadne Malamitsi-Puchner

Articles in Scholarly Journals [Incomplete List]

  1. Cord Blood Ischemia-Modified Albumin Levels in Normal and Intrauterine Growth Restricted Pregnancies
    Mediators of Inflammation, vol. 2008, Article ID 523081, 5 pages, 2008
  2. Role of visfatin, insulin-like growth factor-I and insulin in fetal growth
    Journal of Perinatal Medicine, vol. 35, no. 4, pp. 326–329, 2007
  3. N-terminal parathyroid hormone-related protein levels in human intrauterine growth restricted pregnancies
    Acta Obstetricia et Gynecologica Scandinavica, vol. 86, no. 8, pp. 945–949, 2007
  4. Perinatal Circulating Visfatin Levels in Intrauterine Growth Restriction
    PEDIATRICS, vol. 119, no. 6, pp. e1314–e1318, 2007
  5. Cytokine concentrations during the first days of life
    European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 131, no. 1, pp. 32–35, 2007
  6. Intrauterine growth restriction and circulating neurotrophin levels at term
    Early Human Development, vol. 83, no. 7, pp. 465–469, 2007
  7. Blood visfatin concentrations in normal full-term pregnancies
    Acta Paediatrica, vol. 96, no. 4, pp. 526–529, 2007
  8. Insulin-Like Growth Factor (IGF)-I and Insulin in Normal and Growth-Restricted Mother/Infant Pairs
    Mediators of Inflammation, vol. 2007, Article ID 42646, 6 pages, 2007
  9. Perinatal Changes of Cardiac Troponin-I in Normal and Intrauterine Growth-Restricted Pregnancies
    Mediators of Inflammation, vol. 2007, Article ID 53921, 5 pages, 2007
  10. Perinatal Plasma Monocyte Chemotactic Protein-1 Concentrations in Intrauterine Growth Restriction
    Mediators of Inflammation, vol. 2007, Article ID 65032, 5 pages, 2007
  11. Serum Cystatin C in Pregnancies With Normal and Restricted Fetal Growth
    Reproductive Sciences, vol. 14, no. 1, pp. 37–42, 2007
  12. Causes of Intrauterine Growth Restriction and the Postnatal Development of the Metabolic Syndrome
    Annals of the New York Academy of Sciences, vol. 1092, no. 1, pp. 138–147, 2006
  13. Intrauterine Growth Restriction, Brain-Sparing Effect, and Neurotrophins
    Annals of the New York Academy of Sciences, vol. 1092, no. 1, pp. 293–296, 2006
  14. The Varying Patterns of Neurotrophin Changes in the Perinatal Period
    Annals of the New York Academy of Sciences, vol. 1092, no. 1, pp. 426–433, 2006
  15. Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates
    Early Human Development, vol. 82, no. 4, pp. 235–239, 2006
  16. Investigation of Midtrimester Amniotic Fluid Factors as Potential Predictors of Term and Preterm Deliveries
    Mediators of Inflammation, vol. 2006, Article ID 94381, 5 pages, 2006
  17. Elevated Mid-Trimester Amniotic Fluid ADAM-8 Concentrations as a Potential Risk Factor for Preterm Delivery
    Journal of the Society for Gynecologic Investigation, vol. 13, no. 3, pp. 186–190, 2006
  18. Elevated Second Trimester Amniotic Fluid Interferon ?-Inducible T-Cell a Chemoattractant Concentrations as a Possible Predictor of Preterm Birth
    Journal of the Society for Gynecologic Investigation, vol. 13, no. 1, pp. 25–29, 2006
  19. Possible Early Prediction of Preterm Birth by Determination of Novel Proinflammatory Factors in Midtrimester Amniotic Fluid
    Annals of the New York Academy of Sciences, vol. 1092, no. 1, pp. 440–449, 2006
  20. Inflammatory cytokines and their soluble receptors during delivery and early life
    Acta Obstetricia et Gynecologica Scandinavica, vol. 84, no. 8, pp. 817–818, 2005
  21. Mediators of Inflammation, vol. 2005, no. 6, p. 337, 2005
  22. Mediators of Inflammation, vol. 2005, no. 1, p. 53, 2005
  23. The role of the anti-angiogenic factor endostatin in intrauterine growth restriction
    Journal of the Society for Gynecologic Investigation, vol. 12, no. 3, pp. 195–197, 2005
  24. The influence of the mode of delivery on circulating cytokine concentrations in the perinatal period
    Early Human Development, vol. 81, no. 4, pp. 387–392, 2005
  25. Mediators of Inflammation, vol. 2005, no. 5, p. 293, 2005
  26. Age-related differentiations of Th1/Th2 cytokines in newborn infants
    Mediators of Inflammation, vol. 13, no. 2, pp. 89–92, 2004
  27. Negative Association between Circulating Total Homocysteine and Proinflammatory Chemokines MCP-1 and RANTES in Prepubertal Lean, but Not in Obese, Children
    Journal of Cardiovascular Pharmacology, vol. 44, no. 3, pp. 310–315, 2004
  28. Soluble Fas concentrations in the follicular fluid and oocyte-cumulus complex culture medium from women undergoing in vitro fertilization: Association with oocyte maturity, fertilization, and embryo quality
    Journal of the Society for Gynecologic Investigation, vol. 11, no. 8, pp. 566–569, 2004
  29. Circulating angiogenic factors during periovulation and the luteal phase of normal menstrual cycles
    Fertility and Sterility, vol. 81, no. 5, pp. 1322–1327, 2004
  30. Perinatal changes of brain-derived neurotrophic factor in pre- and fullterm neonates
    Early Human Development, vol. 76, no. 1, pp. 17–22, 2004
  31. Genetic screening for individuals at high risk for type 1 diabetes in the general population using HLA Class II alleles as disease markers. A comparison between three European populations with variable rates of disease incidence
    Diabetes/Metabolism Research and Reviews, vol. 20, no. 4, pp. 322–329, 2004
  32. Chemokines Rantes and Interleukin-8 in the Perinatal Period: Changes in Serum Concentrations
    American Journal of Perinatology, vol. 21, no. 4, pp. 235–240, 2004
  33. In Vitro Fertilization: Angiogenic, Proliferative, and Apoptotic Factors in the Follicular Fluid
    Annals of the New York Academy of Sciences, vol. 997, no. 1, pp. 124–128, 2003
  34. Soluble Fas antigen and soluble Fas ligand in early neonatal life
    Early Human Development, vol. 75, no. 1-2, pp. 1–7, 2003
  35. Apoptosis and proliferation factors in serum and follicular fluid from women undergoing in vitro fertilization
    Fertility and Sterility, vol. 79, no. 3, pp. 634–636, 2003
  36. Cytokine soluble receptors in perinatal and early neonatal life
    Mediators of Inflammation, vol. 12, no. 3, pp. 185–188, 2003
  37. Concentrations of soluble Fas in maternal serum and amniotic fluid during uncomplicated pregnancies
    Journal of the Society for Gynecologic Investigation, vol. 10, no. 3, pp. 158–160, 2003
  38. Indicative Markers of Cell Proliferation and Apoptosis During the Perinatal Period
    American Journal of Perinatology, vol. 20, no. 6, pp. 283–288, 2003
  39. Alterations in Th1/Th2 cytokine concentrations in early neonatal life
    Journal of Maternal-Fetal and Neonatal Medicine, vol. 14, no. 6, pp. 407–410, 2003
  40. Estimation of genetic risk for type 1 diabetes
    American Journal of Medical Genetics, vol. 115, no. 1, pp. 30–36, 2002
  41. Tissue Polypeptide-Specific Antigen Serum Concentrations in Children, Adolescents, and Young Adults With Type 1 Diabetes
    Diabetes Care, vol. 25, no. 1, pp. 240–241, 2002
  42. Concentrations of angiogenic factors in follicular fluid and oocyte-cumulus complex culture medium from women undergoing in vitro fertilization: association with oocyte maturity and fertilization
    Fertility and Sterility, vol. 76, no. 1, pp. 98–101, 2001
  43. Gene analysis of the N-terminal region of the estrogen receptor alpha in preeclampsia
    Steroids, vol. 66, no. 9, pp. 695–700, 2001
  44. Evidence for a suppression of apoptosis in early postnatal life
    Acta Obstetricia et Gynecologica Scandinavica, vol. 80, no. 11, pp. 994–997, 2001
  45. Changes in serum levels of vascular endothelial growth factor in males and females throughout life
    Journal of the Society for Gynecologic Investigation, vol. 7, no. 5, pp. 309–312, 2000
  46. SERUM LEPTIN CONCENTRATIONS DURING THE PERINATAL PERIOD
    American Journal of Perinatology, vol. 17, no. 06, pp. 325–328, 2000
  47. Adhesion Molecules in Early Neonatal Life
    Biology of the Neonate, vol. 78, no. 1, pp. 65–67, 2000
  48. Patterns of inflammatory cytokine serum concentrations during the perinatal period
    Early Human Development, vol. 56, no. 1, pp. 31–38, 1999
  49. Biotin Plasma Levels of theHuman Fetus
    Biology of the Neonate, vol. 74, no. 1, pp. 72–74, 1998
  50. Circulating endothelin-3 and prolactin concentrations in healthy lactating women during the early puerperium
    European Journal of Endocrinology, vol. 138, no. 2, pp. 181–184, 1998
  51. Prevalence study of different hepatitis markers among pregnant Albanian refugees in Greece
    European Journal of Epidemiology, vol. 12, no. 3, pp. 297–301, 1996
  52. Perinatal mortality related to low birth weight
    European Journal of Obstetrics & Gynecology and Reproductive Biology, vol. 41, no. 1, pp. 23–24, 1991
  53. Digoxin levels in the serum of healthy neonates
    European Journal of Pediatrics, vol. 145, no. 4, pp. 314–315, 1986
  54. Combined treatment of neonatal jaundice with phototherapy, cholestyramine, and bicarbonate
    The Journal of Pediatrics, vol. 99, no. 2, pp. 324–325, 1981